Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2234 Neoplasms 2041 Lung Neoplasms 1099 Colorectal Neoplasms 1036 Prostatic Neoplasms 894 Carcinoma, Non-Small-Cell Lung 753 Carcinoma, Hepatocellular 675 Stomach Neoplasms 607 Pancreatic Neoplasms 602 Head and Neck Neoplasms 435 Ovarian Neoplasms 430 Colonic Neoplasms 423 Rectal Neoplasms 406 Uterine Cervical Neoplasms 403 Esophageal Neoplasms 347 Brain Neoplasms 332 Neoplasm Metastasis 324 Melanoma 306 Multiple Myeloma 305 Precursor Cell Lymphoblastic Leukemia-Lymphoma 293 Urinary Bladder Neoplasms 290 Leukemia, Myeloid, Acute 278 Lymphoma 269 Liver Neoplasms 254 Hematologic Neoplasms 253 Endometrial Neoplasms 253 Disease 244 Recurrence 225 Glioma 218 Carcinoma, Renal Cell 207

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Relapsed Ovarian Cancers Patients × Clear all

NCT04152941 2023-09-06

RETROLA

ARCAGY/ GINECO GROUP

Relapsed Ovarian Cancers Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡